Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update assesses the addition of a Chinese patent medicine to tamsulosin to improve sleep quality and nocturia after prostate enuclea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamsulosin (tamsulosin)
  • Unspecified Chinese patent medicine

Snippet

Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Conditions: Benign Prostatic Hyperplasia, Nocturia Associated With Nocturnal Polyuria | Phase 4 | Status: RECRUITING